XTalks

DECEMBER 22, 2021

If the past year is anything to go by, then 2022 will also be a year marked by continued innovations in the life sciences. Here is a look at some life science trends to expect in the coming year, including key themes and topics in the pharmaceutical, biotechnology and medical device industries to keep an eye out for in 2022.

Life Science 98

Life Science RNA Vaccination Vaccine 98

Drug Discovery World

MAY 29, 2024

A recent study led by Stanford Medicine and senior author Dr William Robinson notes that 99% of MS patients have EBV antibodies in their blood, indicating prior infection. Closed Loop Medicine and Pharmanovia TechBio Closed Loop Medicine and pharma company have initiated the OptiZest study and recruited the first patient.

Drugs 52

Drugs Gene Editing Life Science Genome 52

Drug Discovery World

DECEMBER 14, 2023

With leading academic institutions and significant recent investment, Glasgow is shaping up to be an important centre for drug discovery and development in the UK. A centre of excellence for cancer research The announcement of the new Health Innovation Hub follows other examples of significant investment in Glasgow life sciences.

Drugs 75

Drugs Life Science Research Scientist 75

XTalks

MARCH 29, 2022

Jazz Pharmaceuticals has broken ground on a new $100 million manufacturing plant for cannabis-based medicines in the UK. The facility will be constructed in Kent Science Park (KSP) in Sittingbourne, an industrial town in Kent, England. After acquiring British cannabis-based medicine developer GW Pharmaceuticals in 2021 in a $7.2

Medicine 111

Medicine Manufacturing Sales FDA Approval 111

World of DTC Marketing

JANUARY 24, 2022

Venture capitalists have poured $42 billion into drug development over the past three years. Most small biotech companies rely on venture capitalist funding to develop new drugs but is that a good way to go? billion, which was much lower than previous studies, which have placed the average cost of drug development as $2.8

Life Science 225

Life Science Drugs Genetic Disease Development 225

Drug Discovery World

DECEMBER 6, 2023

The UK government has published new terms for the Statutory Scheme for branded medicines, which controls the prices of medicines paid by the NHS. This means that companies will pay a rebate on the sales of branded medicines to the NHS of 21.9% in 2024, 24% in 2025 and 26.8%

Life Science 59

Life Science Branding Medicine Pharma Companies 59

Pharmaceutical Technology

JANUARY 31, 2023

The US omnibus bill passed in late December 2022 will give the agency greater powers to regulate accelerated approval drugs, while the Inflation Reduction Act’s lowering of drug prices will create an uncertain environment for drug developers, he said. That leaves three years for pharma companies to prepare.

Drugs 130

Drugs Regulation Gene Therapy Insulin 130

Drug Discovery World

OCTOBER 16, 2023

The United Kingdom has established itself as a hub for drug discovery expertise worldwide. There is a range of reasons why this area has become focal point for drug discovery, one of which is the fact that it encompasses the University of Oxford and the University of Cambridge, two of the oldest and most prestigious universities in the world.

Drugs 75

Drugs Life Science Gene Therapy Genome 75

pharmaphorum

JANUARY 16, 2023

Two top pharma companies have exited the UK’s voluntary medicines pricing agreement in protest at what the industry has said is a “punitive” system of revenue clawbacks, casting doubt on the future of the scheme in its present form. In December, the ABPI warned that clawback – totalling almost £3.3

Life Science 67

Life Science Drugs Branding Medicine 67

Drug Discovery World

FEBRUARY 10, 2023

DDW Editor Reece Armstrong explores the Scandinavian drug discovery sector and speaks to key players about Sweden’s place in the market. More so, the Karolinska Institute is ranked at number seven in the world for the subjects of life sciences and medicine.

Life Science 52

Life Science Drugs Gene Therapy Manufacturing 52

Delveinsight

JULY 21, 2021

However, some of the key pharma companies at the global level have shifted their focus towards these diverse diseases. Through this article, we have covered the major autoimmune diseases and the key companies striving to transform the treatment landscape of the respective disease.

Pharma Companies 94

Pharma Companies Marketing Insulin Development 94

Drug Discovery World

APRIL 27, 2023

The report notes that the focus on science and pharma throughout the Covid-19 pandemic has resulted in the emergence of new locations as life science hubs and name checks Boston, Massachusetts and San Francisco, California as examples of centres with heightened investment appeal in the life sciences 1.

Life Science 52

Life Science Drugs Research Gene Splicing 52

XTalks

FEBRUARY 15, 2024

US Senator Bernie Sanders, who chairs the Health, Education, Labor, and Pensions (HELP) Committee, managed to bring CEOs of major American pharma companies to a committee hearing to discuss exorbitant US drug pricing. Scapegoating PBMs has been an industry default in trying to explain exorbitant US drug prices.

Drugs 52

Drugs Pharma Companies Pharmacy Regulation 52

World of DTC Marketing

JUNE 22, 2022

PBMs, insurers, pharma companies, and hospitals don’t want to give up their profits even if it’s better for the general population. The company has hired former senior health regulators to help it navigate America’s healthcare bureaucracy. . Then there is the cost of generic drugs.

Pharmacy 227

Pharmacy Generic Drugs Life Science Branding 227

XTalks

OCTOBER 4, 2023

How is the shift toward value-based healthcare affecting drug pricing and reimbursement? There is a world where the way we have done things up until now from a pricing, health economics and access perspective is well-suited to meet the needs of drug reimbursement stakeholders, and where we would probably keep doing it.

Marketing 105

Marketing Development Drugs Gene Therapy 105

pharmaphorum

MARCH 19, 2021

The oceans of health data out there can be overwhelming for pharma companies to manage – but if extracted correctly, the prospect to develop drugs from scratch in as little as a year is very real, says Lifebit CEO, Dr Maria Chatzou Dunford. . The post Digitalising drug discovery appeared first on.

Bioinformatics 57

Bioinformatics Drugs Genome Genomics 57

XTalks

AUGUST 21, 2023

The US Food and Drug Administration (FDA) has approved Ipsen’s groundbreaking Sohonos (palovarotene) capsules for the treatment of fibrodysplasia ossificans progressive (FOP), an ultra-rare bone disease. The median life expectancy of patients with FOP is 56, making it a severe and often misdiagnosed disease.

Drugs 98

Drugs FDA Approval Genetics Clinical Trials 98

XTalks

JANUARY 5, 2024

Eli Lilly launched LillyDirect this week, an online service that provides access to the company’s medicines, including its newly approved weight loss drug Zepbound (tirzepatide). Interestingly, the company’s blockbuster diabetes drug, Mounjaro (tirzepatide), is not available through the new digital service.

Drugs 59

Drugs Pharmacy Cosmetics Insulin 59

XTalks

JULY 20, 2023

Johnson & Johnson has become the fourth major drugmaker to sue the US government in attempts to block a Medicare drug price negotiation program, which is part of the Biden administration’s Inflation Reduction Act (IRA). Astellas had similar things to say in the lawsuit it filed on Friday last week.

Drugs 52

Drugs Manufacturing Medicine Sales 52

Drug Discovery World

AUGUST 8, 2023

DDW’s Megan Thomas takes a deeper look into why India is ramping up drug discovery research, and explores the country’s innovation hubs of interest. According to a report by Deloitte, globally India is the third largest in the world by volume and 11th by value, comprising over 3,000 pharma companies and 10,500 manufacturing facilities 2.

Research 52

Research Drugs Genome Genomics 52

XTalks

MAY 3, 2024

Healthcare company Real Chemistry announced its introduction of IRIS, an insights-as-a-service platform that will deliver all things related to GLP-1 drugs. This includes news on the obesity market, the latest info on current and future GLP-1 drugs and the overall growing influence of GLP-1 therapies. However, only 3.5

Drugs 52

Drugs Clinical Trials Clinical Trials Marketing 52

Drug Discovery World

JANUARY 26, 2023

The invasion of Ukraine by Russia was devastating, and its effects were felt throughout pharma as supply chains were disrupted and companies had to pause any operations they were pursuing in those countries, limiting access to medicines in both the near and long term. Despite this, innovation still occurred.

Development 98

Development Drugs Clinical Trials Clinical Trials 98

Drug Discovery World

OCTOBER 6, 2022

As we start to look beyond the pandemic, which areas of Europe’s drug discovery community should we take note of? The European drug discovery sector is buoyant. This growth is due to factors including a rise in speciality medicines, an increase in lifestyle-driven diseases and a growing population 1. Valued at $14.8 until 2030.

Development 52

Development Drugs Life Science Marketing 52

pharmaphorum

SEPTEMBER 3, 2020

The area is being reimagined as a life sciences and technology hub and is already home to the Francis Crick Institute biomedical research organisation. With AI the pharma industry hopes to reduce the number of drugs that fail during the clinical development process, a huge financial drain on the industry.

Life Science 96

Life Science Engineer Scientist Pharma Companies 96

XTalks

FEBRUARY 14, 2024

Nonetheless, the hearing did highlight important facts and problems about drug pricing in the US, putting the pharma CEOs in the hot seat. Sanders pointed out GoFundMe pages that patients had to set up to try to afford expensive drugs. No apologies, no promises and no acceptance of any wrongdoings. went on for over three hours.

Drugs 52

Drugs Insulin Pharmacy Development 52

pharmaphorum

JANUARY 25, 2022

The Toronto-based company already counts many of the world’s largest pharma companies among its customers, using its platform for a range of tasks such as improving reagent and antibody selection to help scientists run more successful experiments, drawing on data from published studies and organisations’ internal databases.

Life Science 52

Life Science Pharma Companies Reagent Scientist 52

XTalks

JULY 20, 2023

Johnson & Johnson has become the fourth major drugmaker to sue the US government in attempts to block a Medicare drug price negotiation program, which is part of the Biden administration’s Inflation Reduction Act (IRA). Astellas had similar things to say in the lawsuit it filed on Friday last week.

Drugs 40

Drugs Manufacturing Medicine Sales 40

pharmaphorum

JUNE 20, 2022

Paul Verdin, VP of consulting and analytics, and Andreas Hadjivasiliou, managing analyst at Evaluate, tell us about the company’s Orphan Drug Report 2022, which highlights activities within the orphan drug market and forecasts what the future of the industry holds based on data.

Drugs 52

Drugs Marketing Life Science Regulation 52

Pharmaceutical Technology

DECEMBER 19, 2022

Getting funding is going to be more difficult,” says Kyle Faget, partner and co-chair of Foley & Lardner’s Healthcare and Life Sciences Practices, Boston, Massachusetts. Most pharmas will buy biotech companies or smaller pharma groups for the quality of their clinical assets and the drugs on their developments,” he says.

Life Science 173

Life Science Manufacturing Medicine Production 173

XTalks

MARCH 22, 2023

In October 2022, Xtalks celebrated two decades of bringing diverse stakeholders in the life science industry together through first holding physical events, then soon after, hosting exclusively online events. In that time, we’ve gone from running 25 webinars each year to over 400, working with more than 800 expert speakers each year.

Life Science 97

Life Science Drugs FDA Approval Vaccination 97

pharmaphorum

MARCH 17, 2021

Putting together a quarter-billion dollar pharma company from ten mergers in four months is not for the faint-hearted – but that’s what biotech investment guru Francesco de Rubertis has achieved with his latest project Centessa. Initially the company, where de Rubertis will serve as chairman, will focus on 15 drugs.

Pharma Companies 67

Pharma Companies Life Science Drugs Medicine 67

XTalks

JANUARY 15, 2024

Artificial Intelligence (AI) and Machine Learning (ML) Revolutionizing Trials A 2023 study published in Nature Medicine highlighted how AI can be used to link patients to suitable clinical trials and recruit potential participants. billion in 2022, and the trend doesn’t appear to be stalling.

Clinical Trials 105

Clinical Trials Clinical Trials Trials Clinical Research 105

Drug Discovery World

JANUARY 24, 2023

DDW Multimedia Editor Megan Thomas observes the 2023 drug discovery landscape, speaking to industry experts and looking at the foundations of 2022 on which next year will lean. In early November 2022, two Alzheimer’s drugs were tested head-to-head in a first-ever virtual clinical trial 3. We’ve shown that this type of model can work.

Clinical Trials 97

Clinical Trials Clinical Trials Drugs Trials 97

pharmaphorum

NOVEMBER 30, 2022

Veeva Systems invited pharmaphorum to attend its industry summit in Madrid this week, a huge event that gathered together over 1,000 individuals from life sciences and pharma. The question is, how can the journey there be accelerated, when on the horizon awaits a life sciences future very much immersed in speciality medicine?

Life Science 92

Life Science Pharma Companies Sales Marketing 92

Drug Discovery World

OCTOBER 4, 2022

DDW Editor Reece Armstrong explores some of the trends that will be featured in sessions throughout ELRIG Drug Discovery 2022 and the news behind them. There’s no question that cell and gene therapies have emerged as some of the most promising and innovative medicines on the market. . Cell and gene therapies. Automation.

Gene Therapy 52

Gene Therapy Drugs Gene Manufacturing 52

Pharmaceutical Technology

MAY 24, 2023

The ability to modify or introduce genetic material in human cells in such a precise and patient-centered manner clearly constitutes a breakthrough in personalized medicine. CGT drugs fall into two major categories: autologous and allogeneic. What are the general differences in the supply chain of CGT vs. traditional clinical trials?

Clinical Trials 246

Clinical Trials Clinical Trials Gene Therapy Clinical Supply Chain 246

XTalks

MAY 29, 2024

Here, we will deep-dive into the top five fastest growing pharma and biotech companies in 2024, showcasing their innovative strategies and inspiring achievements. Pfizer (Overall Rank 268) Leading the list is one of the most renowned pharma companies in the world: Pfizer.

Medicine 52

Medicine Marketing FDA Approval Development 52